Vascular Pharmacology

Papers
(The H4-Index of Vascular Pharmacology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Corrigendum to “Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis” [Vascular Pharmacology 155 (2024) 107101
Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran92
Graphical abstract TOC39
Biobanks: The unmet need in heart failure management33
Graphical abstract TOC30
The transfer of gut microbiota/metabolites from children to mice affects cardiometabolic development and induces sex-dimorphism in recipients27
Thromboprophylaxis strategies to improve the prognosis of COVID-1926
Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis25
Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies22
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease22
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study22
Animal experimental models of ischemic limbs – A systematic review21
Editorial Board20
A random shuffle method to expand a narrow dataset: A heart failure cohort example20
Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes19
Diabetic neuropathy: Molecular approach a treatment opportunity19
Optical stimulation of endothelial colony forming cells plated on light-sensitive conjugated polymers induces a TRPV1-mediated increase in intracellular Ca2+ concentration19
Prevention of cardiovascular complications in elderly cancer patients19
Exploiting endothelial functions in bone regenerative medicine19
0.10674810409546